State of the art: Pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation

Brain Stimulation

Volumn 1, Issue 3, 2008, Pages 151-163

  Paulus, Walter ^a   Classen, Joseph ^b   Cohen, Leonardo G ^c   Large, Charles H ^d   Di Lazzaro, Vincenzo ^e   Nitsche, Michael ^a   Pascual Leone, Alvaro ^f   Rosenow, F ^g   Rothwell, John C ^h   Ziemann, Ulf ⁱ  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d GSK   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ GOETHE UNIVERSITY   (Germany)

Author keywords

ICF; ICI; pharmacology; SAI; silent period; TMS; transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACAMPROSATE; ANTICONVULSIVE AGENT; ATOMOXETINE; ATROPINE; BACLOFEN; CABERGOLINE; CARBAMAZEPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; GABAPENTIN; GUANFACINE; LAMOTRIGINE; LEVODOPA; LOSIGAMONE; MONOAMINE OXIDASE B INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REBOXETINE; RILUZOLE; SCOPOLAMINE; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SODIUM CHANNEL BLOCKING AGENT; TACRINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; ZOLMITRIPTAN; DRUG;

CHRONIC DRUG ADMINISTRATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DYSTONIA; EPILEPSY; EVOKED MUSCLE RESPONSE; FACILITATION; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LOADING DRUG DOSE; MOTOR CORTEX; NERVE EXCITABILITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN CORTEX; DRUG EFFECTS; PHYSIOLOGY; PROCEDURES;

CEREBRAL CORTEX; EVOKED POTENTIALS, MOTOR; HUMANS; PHARMACEUTICAL PREPARATIONS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 49849085751     PISSN: 1935861X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brs.2008.06.002     Document Type: Review

References (129)

1. Day B.L., Dressler D., Maertens de Noordhout A., et al. Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol 412 (1989) 449-473
2. Ziemann U., Lonnecker S., Steinhoff B.J., and Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. [see comments]. Ann Neurol 40 3 (1996) 367-378
3. Hodgkin A.L., and Huxley A.F. A quantative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond) 116 (1952) 500-544
4. Douglas R., and Neocortex M.K. In: Sheperd G.M. (Ed). The synaptic organization of the brain. 4 ed. (1998), Oxford University Press, New York 459-509
5. Kimiskidis V.K., Papagiannopoulos S., Sotirakoglou K., et al. Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res 163 1 (2005) 21-31
6. Mavroudakis N., Caroyer J.M., Brunko E., and Zegers de Beyl D. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 93 6 (1994) 428-433
7. Chen R., Samii A., Canos M., Wassermann E.M., and Hallett M. Effects of phenytoin on cortical excitability in humans. Neurology 49 (1997) 881-883
8. Boroojerdi B., Battaglia F., Muellbacher W., and Cohen L.G. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 112 5 (2001) 931-937
9. Tergau F., Wischer S., Somal H.S., et al. Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res 56 1 (2003) 67-77
10. Li X., Teneback C.C., Nahas Z., et al. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacol 29 7 (2004) 1395-1407
11. Lee H.W., Seo H.J., Cohen L.G., Bagic A., and Theodore W.H. Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal. Clin Neurophysiol 116 5 (2005) 1105-1112
12. Di Lazzaro V., Oliviero A., Profice P., et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol 547 2 (2003) 485-496
13. Stewart L.M., Walsh V., and Rothwell J.C. Motor and phosphene thresholds: a transcranial magnetic stimulation correlation study. Neuropsychologia 39 4 (2001) 415-419
14. Hess C.W., Mills K.R., and Murray N.M. Responses in small hand muscles from magnetic stimulation of the human brain. J Physiol (Lond) 388 (1987) 397-419
15. Devanne H., Lavoie B.A., and Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res 114 2 (1997) 329-338
16. Rosler K.M., Roth D.M., and Magistris M.R. Trial-to-trial size variability of motor-evoked potentials: a study using the triple stimulation technique. Exp Brain Res 18 (2008) 5-59
17. Di Lazzaro V., Oliviero A., Pilato F., et al. The physiological basis of transcranial motor cortex stimulation in conscious humans. Clin Neurophysiol 115 2 (2004) 255-266
18. Sakai K., Ugawa Y., Terao Y., et al. Preferential activation of different I waves by transcranial magnetic stimulation with a figure-of-eight-shaped coil. Exp Brain Res 113 1 (1997) 24-32
19. Amassian V.E., and Cracco R.Q. Human cerebral cortical responsesto contralateral transcranial stimulation. Neurosurgery 20 1 (1987) 148-155
20. Ziemann U., and Rothwell J.C. I-waves in motor cortex. J Clin Neurophysiol 17 4 (2000 Jul) 397-405
21. Schönle P.W., Isenberg C., Crozier T.A., et al. Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine. Neurosci Lett 101 3 (1989) 321-324
22. Ilic T.V., Meintzschel F., Cleff U., et al. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol (2002) 545.1:153-167
23. Kimiskidis V.K., Papagiannopoulos S., Kazis D.A., et al. Lorazepam-induced effects on silent period and corticomotor excitability. Exp Brain Res 173 4 (2006) 603-611
24. Mohammadi B., Krampfl K., Petri S., et al. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve 33 (2006) 778-784
25. Inghilleri M., Berardelli A., Marchetti P., and Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 109 3 (1996) 467-472
26. Sohn Y.H., Kaelin-Lang A., Jung H.Y., and Hallett M. Effect of levetiracetam on human corticospinal excitability. Neurology 57 5 (2001) 858-863
27. Rigo J.M., Hans G., Nguyen L., et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136 5 (2002) 659-672
28. Korchounov A., Ilic T.V., and Ziemann U. The alpha2-adrenergic agonist guanfacine reduces excitability of human motor cortex through disfacilitation and increase of inhibition. Clin Neurophysiol 114 10 (2003) 1834-1840
29. Di Lazzaro V., Oliviero A., Meglio M., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 111 5 (2000) 794-799
30. Ilic T.V., Korchounov A., and Ziemann U. Methylphenydate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 14 5 (2003) 773-776
31. Plewnia C., Bartels M., Cohen L., and Gerloff C. Noradrenergic modulation of human cortex excitability by the presynaptic alpha(2)-antagonist yohimbine. Neurosci Lett 307 1 (2001) 41-44
32. Plewnia C., Hoppe J., Hiemke C., et al. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett 330 3 (2002) 231-234
33. Plewnia C., Hoppe J., Cohen L.G., and Gerloff C. Improved motor skill acquisition after selective stimulation of central norepinephrine. Neurology 62 11 (2004) 2124-2126
34. Ilic T.V., Korchounov A., and Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett 319 2 (2002) 116-120
35. Gerdelat-Mas A., Loubinoux I., Tombari D., et al. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 27 2 (2005) 314-322
36. Di Lazzaro V., Oliviero A., Profice P., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in human motor cortex. Exp Brain Res 135 (2000) 455-461
37. Schmid U.D., Boll J., Liechti S., and Hess C.W. Influence of some anesthetic agents on muscle responses to transcranial magnetic cortex stimulation: a pilot study in humans. Neurosurgery 30 1 (1992) 85-92
38. Ghaly R.F., Stone J.L., Levy W.J., et al. The effect of neuroleptanalgesia (droperiodol-fentanyl) on motor potentials evoked by transcranial magnetic stimulation in the monkey. J Neurosurgic Anesthesiol 3 2 (1991) 117-123
39. Cantello R., Gianelli M., Civardi C., and Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 42 10 (1992) 1951-1959
40. Fuhr P., Agostino R., and Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 81 4 (1991) 257-262
41. Ziemann U., Netz J., Szelenyi A., and Hömberg V. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 156 1-2 (1993) 167-171
42. Inghilleri M., Berardelli A., Cruccu G., and Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 466 (1993) 521-534
43. Chen R., Lozano A.M., and Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Exp Brain Res 128 (1999) 539-542
44. Ziemann U., Lönnecker S., Steinhoff B.J., and Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109 1 (1996) 127-135
45. Werhahn K.J., Kunesch E., Noachtar S., Benecke R., and Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol (Lond) 517 Pt 2 (1999) 591-597
46. Pierantozzi M., Marciani M.G., Palmieri M.G., et al. Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans. Brain Res 1028 1 (2004) 1-8
47. Connors B.W., Malenka R.C., and Silva L.R. Two inhibitory postsynaptic potentials, and Gabaa and GABAB receptor- mediated responses in neocortex of rat and cat. J Physiol (Lond) 406 (1988) 443-468
48. Huguenard J.R., and Prince D.A. Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 71 6 (1994) 2576-2581
49. McDonnell M.N., Orekhov Y., and Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 173 (2006) 86-93
50. Bowery N.G. GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol 6 1 (2006) 37-43
51. Siebner H.R., Dressnandt J., Auer C., and Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 21 9 (1998) 1209-1212
52. Priori A., Berardelli A., Inghilleri M., Accornero N., and Manfredi M. Motor cortical inhibition and the dopaminergic system: pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 117 Pt 2 (1994) 317-323
53. Ziemann U., Bruns D., and Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 208 3 (1996) 187-190
54. Kroner S., Krimer L.S., Lewis D.A., and Barrionuevo G. Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb Cortex 17 5 (2007) 1020-1032
55. Towers S.K., and Hestrin S. D1-like dopamine receptor activation modulates GABAergic inhibition but not electrical coupling between neocortical fast-spiking interneurons. J Neurosci 28 10 (2008) 2633-2641
56. Cantello R., Tarletti R., and Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 38 3 (2002) 309-327
57. Daskalakis Z.J., Christensen B.K., Chen R., et al. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 59 4 (2002) 347-354
58. Daskalakis Z.J., Christensen B.K., Chen R., et al. Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berl) 170 3 (2003) 255-262
59. Langguth B., Eichhammer P., Spranz C., et al. Modulation of human motor cortex excitability by quetiapine. Psychopharmacology (Berl) 196 4 (2008) 623-629
60. Classen J., Schnitzler A., Binkofski F., et al. The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic stroke. Brain 120 4 (1997) 605-619
61. Mathis J., de Quervain D., and Hess C.W. Dependence of the transcranially induced silent period on the 'instruction set' and the individual reaction time. Electroencephalogr Clin Neurophysiol 109 (1998) 426-435
62. Mathis J., de Quervain D., and Hess C.W. Task-dependent effects on motor-evoked potentials and on the following silent period. J Clin Neurophysiol 16 6 (1999) 556-565
63. Ziemann U., Lönnecker S., and Paulus W. Inhibition of human motor cortex by ethanol: a transcranial magnetic stimulation study. Brain 118 Pt 6 (1995) 1437-1446
64. Conte A., Gilio F., Iezzi E., et al. Attention influences the excitability of cortical motor areas in healthy humans. Exp Brain Res 182 1 (2007) 109-117
65. Kujirai T., Caramia M.D., Rothwell J.C., et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 471 (1993) 501-519
66. Di Lazzaro V., Oliviero A., Profice P., et al. Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr Clin Neurophysiol 109 5 (1998) 397-401
67. Hanajima R., and Ugawa Y. Impaired motor cortex inhibition in patients with ALS: evidence from paired transcranial magnetic stimulation. [letter; comment]. Neurology 51 6 (1998) 1771-1772
68. Di Lazzaro V., Oliviero A., Saturno E., et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564 2 (2005) 661-668
69. Di Lazzaro V., Pilato F., Dileone M., Tonali P.A., and Ziemann U. Dissociated effects of diazepam and lorazepam on short latency afferent inhibition. J Physiol 569 1 (2005) 315-323
70. Jung H.Y., Sohn Y.H., Mason A., Considine E., and Hallett M. Flumazenil does not affect intracortical motor excitability in humans: a transcranial magnetic stimulation study. Clin Neurophysiol 115 2 (2004) 325-329
71. Sanger T.D., Garg R.R., and Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol (2001) 530.2:307-317
72. Deisz R.A. The GABA(B) receptor antagonist CGP 55845A reduces presynaptic GABA(B) actions in neocortical neurons of the rat in vitro. Neuroscience 93 4 (1999) 1241-1249
73. Deisz R.A. GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro. Neuropharmacology 38 11 (1999) 1755-1766
74. Lang N., Sueske E., Hasan A., Paulus W., and Tergau F. Pregabalin exerts oppositional effects on different inhibitory circuits in human motor cortex: a double-blind, placebo-controlled transcranial magnetic stimulation study. Epilepsia 47 5 (2006) 813-839
75. Reis J., Tergau F., Hamer H.M., et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 43 10 (2002) 1149-1156
76. Ilic T.V., Meintzschel F., Cleff U., et al. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 545 Pt 1 (2002) 153-167
77. Ziemann U., Chen R., Cohen L.G., and Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51 (1998) 1320-1324
78. Schwenkreis P., Witscher K., Janssen F., et al. Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett 270 (1999) 137-140
79. Schwenkreis P., Liepert J., Witscher K., et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. Exp Brain Res 135 (2000) 293-299
80. Ziemann U., Tergau F., Bruns D., Baudewig J., and Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105 6 (1997) 430-437
81. Korchounov A., Ilic T.V., and Ziemann U. TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortex. J Neural Transm 114 2 (2007) 223-229
82. Herwig U., Bräuer K., Connemann B., Spitzer M., and Schönfeldt-Lecuona C. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacol 164 (2002) 228-232
83. Gilbert D.L., Ridel K.R., Sallee F.R., et al. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 31 2 (2006) 442-449
84. Korchounov A., Ilic T.V., Schwinge T., and Ziemann U. Modification of motor cortical excitability by an acetylcholine-esterase inhibitor. Exp Brain Res 164 (2005) 399-405
85. Nardone R., Ausserer H., Bratti A., et al. Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Acta Neurol Scand 114 4 (2006) 244-249
86. Robol E., Fiaschi A., and Manganotti P. Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci 221 1-2 (2004) 41-46
87. Eichhammer P., Langguth B., Wiegand R., et al. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology (Berl) 166 3 (2003) 294-297
88. Roshan L., Paradiso G.O., and Chen R. Two phases of short-interval intracortical inhibition. Exp Brain Res 151 3 (2003) 330-337
89. Fisher R.J., Nakamura Y., Bestmann S., Rothwell J.C., and Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 143 2 (2002) 240-248
90. Hanajima R., Furubayashi T., Iwata N.K., et al. Further evidence to support different mechanisms underlying intracortical inhibition of the motor cortex. Exp Brain Res 151 4 (2003) 427-434
91. Vucic S., Howells J., Trevillion L., and Kiernan M.C. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 33 4 (2006) 477-486
92. Ziemann U., Rothwell J.C., and Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol (Lond) 496 Pt 3 (1996) 873-881
93. Di Lazzaro V., Pilato F., Oliviero A., et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. J Neurophysiol 96 4 (2006) 1765-1771
94. Hanajima R., Ugawa Y., Terao Y., et al. Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J Physiol 509 (1998) 607-618
95. Hwa G.G., and Avoli M. Excitatory postsynaptic potentials recorded from regular-spiking cells in layers II/III of rat sensorimotor cortex. J Neurophysiol 67 3 (1992) 728-737
96. Bresink I., Benke T.A., Collett V.J., et al. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol 119 2 (1996) 195-204
97. Strafella A.P., and Paus T. Cerebral blood-flow changes induced by paired-pulse transcranial magnetic stimulation of the primary motor cortex. J Neurophysiol 85 6 (2001) 2624-2629
98. Ziemann U., Tergau F., Wassermann E.M., et al. Demonstration of facilitatory I-wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J Physiol (Lond) 511 1 (1998) 181-190
99. Chen R., and Garg R. Facilitatory I wave interaction in proximal arm and lower limb muscle representations of the human motor cortex. J Neurophysiol 83 3 (2000) 1426-1434
100. Hanajima R., Ugawa Y., Terao Y., et al. Mechanisms of intracortical I-wave facilitation elicited with paired- pulse magnetic stimulation in humans. J Physiol 538 Pt 1 (2002) 253-261
101. Tokimura H., Ridding M.C., Tokimura Y., Amassian V.E., and Rothwell J.C. Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex. Electroencephalogr Clin Neurophysiol 101 4 (1996) 263-272
102. Di Lazzaro V., Rothwell J.C., Oliviero A., et al. Intracortical origin of the short latency facilitation produced by pairs of threshold magnetic stimuli applied to human motor cortex. Exp Brain Res 129 4 (1999) 494-499
103. Ziemann U., Tergau F., Wischer S., Hildebrandt J., and Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex: a paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol 109 (1998) 321-330
104. Wischer S., Paulus W., Sommer M., and Tergau F. Piracetam affects facilitatory I-wave interaction in the human motor cortex. Clin Neurophysiol 112 2 (2001) 275-279
105. Claus D., Weis M., Jahnke U., Plewe A., and Brunhölzl C. Corticospinal conduction studied with magnetic double stimulation in the intact human. J Neurol Sci 111 2 (1992) 180-188
106. Valls-Sole J., Pascual-Leone A., Wassermann E.M., and Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 85 6 (1992) 355-364
107. Nakamura H., Kitagawa H., Kawaguchi Y., and Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol (Lond) 498 (1997) 817-823
108. Di Lazzaro V., Oliviero A., Mazzone P., et al. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clin Neurophysiol 113 11 (2002) 1673-1679
109. Tokimura H., Di Lazzaro V., Tokimura Y., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523 Pt 2 (2000) 503-513
110. Di Lazzaro V., Pilato F., Dileone M., et al. Segregating two inhibitory circuits in human motor cortex at the level of GABAA receptor subtypes: a TMS study. Clin Neurophysiol 118 10 (2007) 2207-2214
111. Di Lazzaro V., Oliviero A., Tonali P.A., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59 3 (2002) 392-397
112. Di Lazzaro V., Oliviero A., Pilato F., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76 8 (2005) 1064-1069
113. Reutens D.C., Berkovic S.F., Macdonell R.A., and Bladin P.F. Magnetic stimulation of the brain in generalized epilepsy: reversal of cortical hyperexcitability by anticonvulsants. Ann Neurol 34 3 (1993) 351-355
114. Cantello R., Civardi C., Varrasi C., et al. Excitability of the human epileptic cortex after chronic valproate: a reappraisal. Brain Res 1099 1 (2006) 160-166
115. Manganotti P., Bongiovanni L.G., Zanette G., Turazzini M., and Fiaschi A. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Epilepsia 40 3 (1999) 316-321
116. Smith M.J., Keel J.C., Greenberg B.D., Adams L.F., Schmidt P.J., Rubinow D.A., and Wassermann E.M. Menstrual cycle effects on cortical excitability. Neurology 53 9 (1999) 2069-2072
117. Hattemer K., Knake S., Reis J., Rochon J., Oertel W.H., Rosenow F., and Hamer H.M. Excitability of the motor cortex during ovulatory and anovulatory cycles: A transcranial magnetic stimulation study. Clin Endocrinol 66 3 (2007) 387-393
118. Epstein CM, Girard-Siqueira L, Ehrenberg JA. Prolonged neurophysiologic effects of levetiracetam after oral administration in humans. Epilepsia 2008. [In press.]
119. Ziemann U. Pharmacology of TMS measures. In: Wassermann E.M., Epstein C., Ziemann U., Walsh V., and Paus T. (Eds). Oxford handbook of transcranial stimulation (2008), Oxford University Press, London
120. Rizzo V., Quartarone A., Bagnato S., et al. Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation. Neurol Sci 22 3 (2001) 229-232
121. Sohn Y.H., Kaelin-Lang A., Jung H.Y., and Hallett M. Effect of levetiracetam on human corticospinal excitability. Neurology 57 5 (2001) 858-863
122. Reis J., Wentrup A., Hamer H.M., et al. Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function-a TMS study. Epilepsy Res 62 1 (2004) 41-51
123. Wischer S., Paulus W., Sommer M., and Tergau F. Piracetam affects facilitatory I-wave interaction in the human motor cortex. Clin Neurophysiol 112 2 (2001) 275-279
124. Wohlfarth K., Schneider U., Haacker T., et al. Acamprosate reduces motor cortex excitability determined by transcranial magnetic stimulation. Neuropsychobiology 42 4 (2000) 183-186
125. Orth M., Amann B., Ratnaraj N., Patsalos P.N., and Rothwell J.C. Caffeine has no effect on measures of cortical excitability. Clin Neurophysiol 116 2 (2005) 308-314
126. Specterman M., Bhuiya A., Kuppuswamy A., et al. The effect of an energy drink containing glucose and caffeine on human corticospinal excitability. Physiol Behav 83 5 (2005) 723-728
127. Nardone R., Buffone E., Covi M., Lochner P.G., and Tezzon F. Changes in motor cortical excitability in humans following orally administered theophylline. Neurosci Lett 355 1-2 (2004) 65-68
128. Liepert J., Allstadt-Schmitz J., and Weiller C. Motor excitability and motor behaviour after modafinil ingestion-a double-blind placebo-controlled cross-over trial. J Neural Transm 111 6 (2004) 703-711
129. Münchau A., Langosch J.M., Gerschlager W., et al. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 76 4 (2005) 527-533